Details of Protein
| General Information of Protein (ID: PRT00280) | |||||
|---|---|---|---|---|---|
| Name | Succinate-hydroxymethylglutarate CoA-transferase (SUGCT) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
SuccinylCoA:glutarate-CoA transferase; Sugct
|
||||
| Gene Name | Sugct | Gene ID | |||
| UniProt ID | |||||
| Family | Transferases (EC 2) | ||||
| EC Number | EC: 2.8.3.13 (Click to Show/Hide the Complete EC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MLWMLARAVAFRRPGRGLAGGRGLWTGRPQSDCDSMKPLEGVRILDLTRVLAGPFATMNL
GDLGAEVIKVERPGAGDDTRSWGPPFVNTESTYFLSVNRNKKSIAVNIKDPRGVRIVKEL AAICDVFVENYVPGKLSEMGLGYEDIDKIAPHIIYCSITGYGQTGPMSHRAGYDAIASAM SGLMHITGPEDGDPVRPGVAMTDLATGLFAYGAIMAGLLQRYRTGKGLFIDCNLLSSQVA CLTQVAANYLIGQKEAKRWGTAHGSIVPYQAFKTKDGYLVIGAGNNQQFAVVCKILNLPE LIDDCKYRTNHLRVQNRKELVKILSARFAEEVTAKWLCLFEGSGIPYGPINSLKDVFSEA QVLHNGLVMEMNHPTVGKISVPGPAVRYSKFKMSEAKPPPLLGQHTRHILKEVLRYDEGA IEKLLCSGVIEQHETK |
||||
| Function | Catalyzes the succinyl-CoA-dependent conversion of glutarate to glutaryl-CoA. Can use different dicarboxylic acids as CoA acceptors, the preferred ones are glutarate, succinate, adipate, and 3-hydroxymethylglutarate. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | ||||||
| FAD | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | FAD concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of FAD levels compared with control group. | |||||
| Lipid-related molecules | ||||||
| Linoelaidylcarnitine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Linoelaidylcarnitine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of linoelaidylcarnitine levels compared with control group. | |||||
| Lipids and lipid-like molecules | ||||||
| Adipic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Adipic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of adipic acid levels compared with control group. | |||||
| cis-5-Tetradecenoylcarnitine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | cis-5-Tetradecenoylcarnitine concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the decrease of cis-5-Tetradecenoylcarnitine levels compared with control group. | |||||
| Linoleic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Linoleic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of linoleic acid levels compared with control group. | |||||
| Octadec-9-enoic Acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Octadec-9-enoic Acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of octadec-9-enoic Acid levels compared with control group. | |||||
| Organic acids | ||||||
| Egtazic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Egtazic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of egtazic acid levels compared with control group. | |||||
| Organic acids and derivatives | ||||||
| Glutaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Glutaric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of glutaric acid levels compared with control group. | |||||
| Tyrosyl-Tyrosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Tyrosyl-Tyrosine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of tyrosyl-tyrosine levels compared with control group. | |||||
| Organic oxygen compounds | ||||||
| Octanal | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Octanal concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of octanal levels compared with control group. | |||||
| Organoheterocyclic compounds | ||||||
| 5-Hydroxy-L-tryptophan | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | 5-Hydroxy-L-tryptophan concentration: decrease | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the decrease of 5-hydroxy-L-tryptophan levels compared with control group. | |||||
| Riboflavin cyclic-4',5'-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Sugct | |||||
| Induced Change | Riboflavin cyclic-4',5'-phosphate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Diabetes mellitus [ICD-11: 5A14] | |||||
| Details | It is reported that knockout of Sugct leads to the increase of riboflavin cyclic-4',5'-phosphate levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

